{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:05:10Z","timestamp":1792764310984,"version":"4.5.0"},"reference-count":40,"publisher":"Massachusetts Medical Society","issue":"8","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100014013","name":"United Kingdom Research and Innovation","doi-asserted-by":"publisher","award":["MC_PC_19056"],"award-info":[{"award-number":["MC_PC_19056"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["MC_PC_19056"],"award-info":[{"award-number":["MC_PC_19056"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2021,2,25]]},"DOI":"10.1056\/nejmoa2021436","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T12:04:22Z","timestamp":1594987462000},"page":"693-704","source":"Crossref","is-referenced-by-count":8154,"title":["Dexamethasone in Hospitalized Patients with Covid-19"],"prefix":"10.1056","volume":"384","author":[{"name":"The RECOVERY Collaborative Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019.","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-733.31978945","journal-title":"N Engl J Med"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: a model-based analysis.","volume":"20","author":"Verity R","year":"2020","unstructured":"Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020;20:669-677.32240634","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-1062.32171076","journal-title":"Lancet"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513.32007143","journal-title":"Lancet"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/cid\/ciaa243","article-title":"Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China.","volume":"71","author":"Cao J","year":"2020","unstructured":"Cao J, Tu W-J, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China. Clin Infect Dis 2020;71:748-755.32239127","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","volume":"46","author":"Ruan Q","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846-848.32125452","journal-title":"Intensive Care Med"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.","volume":"369","author":"Docherty AB","year":"2020","unstructured":"Docherty AB, Harrison EM, Green CA, et al. Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985-m1985.32444460","journal-title":"BMJ"},{"key":"e_1_3_5_9_2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report.","volume":"383","author":"Beigel JH","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 \u2014 final report. N Engl J Med 2020;383:1813-1826.32445440","journal-title":"N Engl J Med"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.","volume":"20","author":"Carsana L","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020;20:1135-1140.32526193","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.","volume":"12","author":"de Jong MD","year":"2006","unstructured":"de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.16964257","journal-title":"Nat Med"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.","volume":"136","author":"Wong CK","year":"2004","unstructured":"Wong CK, Lam CWK, Wu AKL, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004;136:95-103.15030519","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJMcibr1304414","article-title":"Influenza \u2014 time to target the host?","volume":"369","author":"Baillie JK","year":"2013","unstructured":"Baillie JK, Digard P. Influenza \u2014 time to target the host? N Engl J Med 2013;369:191-193.23841736","journal-title":"N Engl J Med"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.31986264","journal-title":"Lancet"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19.","volume":"368","author":"Moore JB","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020;368:473-474.32303591","journal-title":"Science"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia.","volume":"395","author":"Shang L","year":"2020","unstructured":"Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 2020;395:683-684.32122468","journal-title":"Lancet"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.","volume":"395","author":"Russell CD","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473-475.32043983","journal-title":"Lancet"},{"key":"e_1_3_5_18_2","unstructured":"Corral-Gudino L Bahamonde A Arnaiz-Revillas F et al. GLUCOCOVID: a controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia. June 18 2020 (https:\/\/www.medrxiv.org\/content\/10.1101\/2020.06.17.20133579v1). preprint."},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"m1936","DOI":"10.1136\/bmj.m1936","article-title":"Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review.","volume":"369","author":"Dagens A","year":"2020","unstructured":"Dagens A, Sigfrid L, Cai E, et al. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ 2020;369:m1936-m1936.32457027","journal-title":"BMJ"},{"key":"e_1_3_5_20_2","first-page":"183","article-title":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","volume":"43","author":"Zhao JP","year":"2020","unstructured":"Zhao JP, Hu Y, Du RH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:183-184. (In Chinese.)32164084","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069.32031570","journal-title":"JAMA"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.","volume":"368","author":"Xu XW","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606-m606.32075786","journal-title":"BMJ"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis.","volume":"324","author":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group","year":"2020","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 2020;324:1330-1341.32876694","journal-title":"JAMA"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomized trials?","volume":"3","author":"Yusuf S","year":"1984","unstructured":"Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984;3:409-422.6528136","journal-title":"Stat Med"},{"key":"e_1_3_5_25_2","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2:349-360.2899772","journal-title":"Lancet"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","article-title":"The magic of randomization versus the myth of real-world evidence.","volume":"382","author":"Collins R","year":"2020","unstructured":"Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. N Engl J Med 2020;382:674-678.32053307","journal-title":"N Engl J Med"},{"key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12916-016-0760-x","article-title":"Modernising epidemic science: enabling patient-centred research during epidemics.","volume":"14","author":"Rojek AM","year":"2016","unstructured":"Rojek AM, Horby PW. Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med 2016;14:212-212.27989237","journal-title":"BMC Med"},{"key":"e_1_3_5_28_2","unstructured":"Whitty C. Dexamethasone in the treatment of COVID-19: implementation and management of supply for treatment in hospitals. London: Medicines and Healthcare Products Regulatory Agency June 16 2020 (https:\/\/www.cas.mhra.gov.uk\/ViewandAcknowledgment\/ViewAlert.aspx?AlertID=103054)."},{"issue":"9","key":"e_1_3_5_29_2","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects.","volume":"3","author":"Stockman LJ","year":"2006","unstructured":"Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006;3(9):e343-e343.16968120","journal-title":"PLoS Med"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","volume":"197","author":"Arabi YM","year":"2018","unstructured":"Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med 2018;197:757-767.29161116","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/CCM.0000000000004093","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","volume":"48","author":"Lansbury LE","year":"2020","unstructured":"Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Shen Lim W. Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis. Crit Care Med 2020;48(2):e98-e106.31939808","journal-title":"Crit Care Med"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis.","volume":"163","author":"Siemieniuk RA","year":"2015","unstructured":"Siemieniuk RA, Meade MO, Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med 2015;163:519-528.26258555","journal-title":"Ann Intern Med"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.","volume":"31","author":"Lee N","year":"2004","unstructured":"Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol 2004;31:304-309.15494274","journal-title":"J Clin Virol"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/600383","article-title":"Viral loads and duration of viral shedding in adult patients hospitalized with influenza.","volume":"200","author":"Lee N","year":"2009","unstructured":"Lee N, Chan PKS, Hui DSC, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492-500.19591575","journal-title":"J Infect Dis"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(04)16255-7","article-title":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome.","volume":"363","author":"Cheng PKC","year":"2004","unstructured":"Cheng PKC, Wong DA, Tong LKL, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 2004;363:1699-1700.15158632","journal-title":"Lancet"},{"key":"e_1_3_5_36_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.","volume":"20","author":"To KK-W","year":"2020","unstructured":"To KK-W, Tsang OT-T, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20:565-574.32213337","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijid.2020.05.030","article-title":"Viral dynamics in asymptomatic patients with COVID-19.","volume":"96","author":"Zhou R","year":"2020","unstructured":"Zhou R, Li F, Chen F, et al. Viral dynamics in asymptomatic patients with COVID-19. Int J Infect Dis 2020;96:288-290.32437933","journal-title":"Int J Infect Dis"},{"key":"e_1_3_5_38_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19.","volume":"26","author":"He X","year":"2020","unstructured":"He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020;26:672-675.32296168","journal-title":"Nat Med"},{"key":"e_1_3_5_39_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019.","volume":"581","author":"W\u00f6lfel R","year":"2020","unstructured":"W\u00f6lfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465-469.32235945","journal-title":"Nature"},{"key":"e_1_3_5_40_2","unstructured":"COVID-19 treatment guidelines: corticosteroids. Bethesda MD: National Institutes of Health 2020 (https:\/\/www.covid19treatmentguidelines.nih.gov\/dexamethasone\/)."},{"key":"e_1_3_5_41_2","first-page":"m3379","article-title":"A living WHO guideline on drugs for Covid-19.","volume":"370","author":"Siemieniuk R","year":"2020","unstructured":"Siemieniuk R, Rochwerg B, Agoritsas T, et al. A living WHO guideline on drugs for Covid-19. BMJ 2020;370:m3379-m3379.32887691","journal-title":"BMJ"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2021436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:36:27Z","timestamp":1711485387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2021436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,2,25]]}},"alternative-id":["10.1056\/NEJMoa2021436"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2021436","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.22.20137273","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.738341916.793577274","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}